Abstract
Overexpression of the oncogene ERBB2 is present in nearly 30% of breast tumors and its expression isdirectly associated with bad prognosis, although its molecular pathways are still poorly understood. In order to investigate the role of ERBB2, our research group started a project aiming the identification of genes that are modulated by ERBB2 overexpression. We detected a strong associatio…